This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Mcgill University, National Institute of Health and Medical Research, Université D'angers. Active years: 2015.
Company Filing History:
1 out of 570 
1 out of 1,853 
1 out of 55 
Years Active: 2015
Title: Arnaud Bocquet: Innovator in Peptide Research
Introduction
Arnaud Bocquet is a notable inventor based in Castres, France. He has made significant contributions to the field of biochemistry, particularly in the development of peptides that can influence cellular processes. His work is particularly relevant in the context of cancer research and treatment.
Latest Patents
Bocquet holds a patent for a peptide capable of altering tubulin polymerization and its use for inhibiting cell proliferation. This invention focuses on a peptide derived from intermediate filaments and an intermediate filament fragment. It is designed to alter tubulin polymerization, which is crucial for cell division. The implications of this invention are profound, as it can lead to the development of medicines aimed at preventing or treating diseases characterized by uncontrolled cell proliferation, such as cancers.
Career Highlights
Throughout his career, Arnaud Bocquet has worked with prestigious institutions, including McGill University and the National Institute of Health and Medical Research. His research has contributed to a deeper understanding of cellular mechanisms and has opened new avenues for therapeutic interventions.
Collaborations
Bocquet has collaborated with notable colleagues in his field, including Joël Eyer and Alan Peterson. These collaborations have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Arnaud Bocquet's innovative work in peptide research exemplifies the potential of scientific inquiry to address critical health challenges. His contributions to the understanding of cell proliferation and the development of therapeutic strategies are invaluable.